You are here

Cell-Free Protein Labeling for Drug Discovery

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 2R44GM063369-02
Agency Tracking Number: GM063369
Amount: $749,938.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: PHS2004-2
Timeline
Solicitation Year: 2004
Award Year: 2004
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
AMBERGEN, INC. 1106 COMMONWEALTH AVE
BOSTON, MA 02215
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 SADANAND Gite
 (617) 975-0683
 SADANAND@AMBERGEN.COM
Business Contact
 NORMAN PRIEBATSCH
Phone: (617) 975-0688
Email: NEP@AMBERGEN.COM
Research Institution
N/A
Abstract

DESCRIPTION (provided by applicant): The human genome has opened a new chapter for drug discovery. In contrast to conventional drug discovery methods, which screen a drug library against a single protein target, the entire protein complement of the genome

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government